Search
Login
Register
Menu
Last issue
Home
News
CongressUpdate
Guidelines
Specials
Links
Reimbursement News
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia
Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia
€
3.03
Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia quantity
Add to cart
SKU:
product-article-16264
Category:
General
Description
Description
Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia
Related products
Article: Highlights in breast cancer
€
3.03
Add to cart
Article: Highlights in digestive oncology
€
3.03
Add to cart
Article: Highlights in urologic cancer
€
3.03
Add to cart
Article: Highlights in respiratory oncology
€
3.03
Add to cart